Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€262.20
03.07.23
€270.00
03.07.24
-25.51%
27.04.24

Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.60
25.04.24
-
25.04.25
-1.53%
27.04.24

Could be worthwhile Investment >10% per year
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€1.85
25.04.24
-
25.04.25
-4.27%
27.04.24

buy
Actinium Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€6.14
25.04.24
-
25.04.25
4.89%
27.04.24

buy
X4 Pharmaceuticals, Inc.

Start price
Target price
Perf. (%)
€1.08
25.04.24
-
25.04.25
0.83%
27.04.24

iBio Inc.

Start price
Target price
Perf. (%)
€0.99
26.04.23
€0.20
26.04.24
-81.42%
27.04.24

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
Advaxis Inc.

Start price
Target price
Perf. (%)
€0.059
26.04.23
-
26.04.24
-
27.04.24

Ampio Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.060
26.04.23
-
26.04.24
-
27.04.24

buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€30.42
26.04.23
€72.10
26.04.24
-32.05%
27.04.24

buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.81
26.04.23
-
26.04.24
-89.67%
27.04.24

buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€10.85
23.04.24
€15.00
23.04.25
2.75%
27.04.24

Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.68
23.04.24
-
23.04.25
-16.85%
27.04.24

Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.07
13.04.24
€1.00
13.04.25
-6.54%
27.04.24

Probably not worthwhile Investment
Lower EBIT Margin than peer group
Bad rating
ROE lower than 10% per year
Inotiv Inc.

Start price
Target price
Perf. (%)
€5.50
13.04.24
€4.00
13.04.25
-31.27%
27.04.24

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Little Investments for future growth
Enlivex Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.51
13.04.24
€2.00
13.04.25
-9.27%
27.04.24

negative Cash Flow expected
Few uniques
Growths slower than the competition
Below average Marketposition
buy
Alterity Therapeutics Ltd. ADR

Start price
Target price
Perf. (%)
€3.80
13.04.24
€2.00
13.04.25
-56.84%
27.04.24

buy
Amgen Inc.

Start price
Target price
Perf. (%)
€222.60
24.04.23
€263.03
24.04.24
15.03%
25.04.24

buy
Geron Corp.

Start price
Target price
Perf. (%)
€2.40
24.04.23
€3.63
24.04.24
37.50%
25.04.24

buy
Heron Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.40
24.04.23
€6.35
24.04.24
-5.00%
25.04.24

Trevena Inc.

Start price
Target price
Perf. (%)
€0.82
23.04.23
-
23.04.24
-60.39%
24.04.24

Bellicum Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.21
22.04.23
-
22.04.24
-22.38%
23.04.24

Cellectar BioSciences Inc.

Start price
Target price
Perf. (%)
€1.32
22.04.23
-
22.04.24
127.27%
23.04.24

Cyclacel Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.51
22.04.23
-
22.04.24
-66.04%
23.04.24

Genocea Biosciences Inc.

Start price
Target price
Perf. (%)
€0.009
22.04.23
-
22.04.24
-
23.04.24

buy
Natural Alternat.

Start price
Target price
Perf. (%)
€7.95
22.04.23
-
22.04.24
-27.04%
23.04.24